Cancer cells often experience high levels of ER stress due to their rapid growth and altered metabolism. The activation of ATF6 helps these cells survive by enhancing their capacity to manage protein folding and degradation. This adaptation is crucial for the survival and proliferation of tumor cells under stressful conditions, making ATF6 a potential target for cancer therapy.
